Personal Finance Show: Benefits of biotech and diversifying income episode artwork

EPISODE · May 10, 2019 · 24 MIN

Personal Finance Show: Benefits of biotech and diversifying income

from Investors' Chronicle

In this week's show Carl Harald Janson, manager of International Biotechnology Trust, sets out the arguments for investing in biotech companies and says which areas of this sector offer particularly good opportunities. He also explains how the trust gets exposure to unquoted companies and is able to pay attractive dividends. And personal finance writer Zayani Bhatt explains why you need to diversify your sources of equity income, and highlights a good area and fund with which to do it.Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Investors' Chronicle is a service by the Financial Times. Hosted on Acast. See acast.com/privacy for more information.

Episode metadata supplied by the publisher feed · Published May 10, 2019

Embed this episode

NOW PLAYING

Personal Finance Show: Benefits of biotech and diversifying income

0:00 24:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Investors' Chronicle?

This episode is 24 minutes long.

When was this Investors' Chronicle episode published?

This episode was published on May 10, 2019.

Can I download this Investors' Chronicle episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!